{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:57:58Z","timestamp":1761850678376,"version":"build-2065373602"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/pat.0b013e32834e786e","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T04:28:45Z","timestamp":1324528125000},"page":"129-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities"],"prefix":"10.1016","volume":"44","author":[{"given":"Kai M.","family":"Eggers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Venge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e32834e786e_bib0005","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0010","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0015","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcmg.2008.12.006","article-title":"B-type natriuretic peptides and echocardio- graphic measures of cardiac structure and function","volume":"2","author":"Troughton","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(97)03034-1","article-title":"Biochemical detection of left-ventricular systolic dysfunction","volume":"351","author":"McDonagh","year":"1998","journal-title":"Lancet"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/00004872-200018080-00018","article-title":"Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population","volume":"18","author":"Luchner","year":"2000","journal-title":"J Hypertens"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0035","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/hrt.2003.014258","article-title":"Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations","volume":"90","author":"Hobbs","year":"2004","journal-title":"Heart"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0040","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jama.288.10.1252","article-title":"Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham study","volume":"288","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1388-9842(03)00154-5","article-title":"Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography","volume":"5","author":"Ng","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0050","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1161\/01.CIR.0000130845.38133.8F","article-title":"Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study","volume":"109","author":"Redfield","year":"2004","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejheart.2004.12.010","article-title":"BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy","volume":"7","author":"Lukowicz","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2005.09.025","article-title":"Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community. Determinants and detection of left ventricular dysfunction","volume":"47","author":"Costello-Boerrigter","year":"2006","journal-title":"JAm Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0065","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ahj.2008.12.017","article-title":"Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study","volume":"157","author":"de Lemos","year":"2009","journal-title":"Am Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.2003.026021","article-title":"Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N- terminal pro-brain natriuretic peptide concentrations in a large sample of the general population","volume":"90","author":"Groenning","year":"2004","journal-title":"Heart"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0075","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/eurheartj\/ehi410","article-title":"What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?","volume":"26","author":"Galasko","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ahj.2006.05.007","article-title":"Population-based detection of systolic and diastolic dysfunction with amino-terminal pro- B-type natriuretic peptide","volume":"152","author":"Abhayaratna","year":"2006","journal-title":"Am Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/hc0502.103010","article-title":"Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings (Erratum in: Circulation 2002; 106: 387.)","volume":"105","author":"Lubien","year":"2002","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1388-9842(03)00041-2","article-title":"Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure","volume":"5","author":"Mariano-Goulart","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0095","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jacc.2003.09.051","article-title":"Clinical significance of brain natriuretic peptide in primary pulmonary hypertension","volume":"43","author":"Leuchte","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0100","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0735-1097(03)00486-8","article-title":"Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation","volume":"41","author":"Sutton","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0105","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/CIRCULATIONAHA.106.654210","article-title":"B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study","volume":"115","author":"Bergler-Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0110","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1540-8167.1999.tb00263.x","article-title":"Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation","volume":"10","author":"Tuinenburg","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0115","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1096\/fj.03-1336fje","article-title":"Acute myocardial hypoxia increases BNP gene expression","volume":"18","author":"Goetze","year":"2004","journal-title":"FASEB J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0120","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2004.07.057","article-title":"Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia","volume":"44","author":"Sabatine","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0125","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.amjcard.2005.06.073","article-title":"Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study)","volume":"96","author":"Abdullah","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ahj.2005.12.009","article-title":"Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?","volume":"151","author":"Kragelund","year":"2006","journal-title":"Am Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.2008.145425","article-title":"Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease","volume":"95","author":"Peer","year":"2009","journal-title":"Heart"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/000456320103800501","article-title":"Measurement of cardiac troponins","volume":"38","author":"Collinson","year":"2001","journal-title":"Ann Clin Biochem"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-142-9-200505030-00015","article-title":"Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded","volume":"142","author":"Jeremias","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0150","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1373\/49.6.880","article-title":"Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy","volume":"49","author":"Venge","year":"2003","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0155","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/CIRCULATIONAHA.105.570762","article-title":"Troponin I as a predictor of coronary heart disease and death in 70-year old apparently healthy men","volume":"113","author":"Zethelius","year":"2006","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0160","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCULATIONAHA.105.609974","article-title":"Prevalence and determinants of troponin T elevation in the general population","volume":"113","author":"Wallace","year":"2006","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2008.04.033","article-title":"Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study","volume":"52","author":"Daniels","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0170","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jacc.2009.05.051","article-title":"Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia","volume":"54","author":"Venge","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0175","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population (Erratum in: JAMA 2011;305: 1200.)","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0180","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ahj.2010.02.036","article-title":"Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle- aged men without overt cardiovascular disease","volume":"159","author":"Otsuka","year":"2010","journal-title":"Am Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0185","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"deFilippi","year":"2010","journal-title":"JAMA"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0190","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/eurheartj\/ehn327","article-title":"Prevalence and pathophysiologic mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects","volume":"29","author":"Eggers","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0195","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2010.06.016","article-title":"Troponin elevation in heart failure prevalence, mechanisms, and clinical implications","volume":"56","author":"Kociol","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0200","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"NEngl J Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0205","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/ATVBAHA.109.200394","article-title":"The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T","volume":"30","author":"Laufer","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMcibr0903347","article-title":"Cardiomyocyte renewal","volume":"361","author":"Parmacek","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0215","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/0735-1097(95)00282-8","article-title":"Gender differences and aging: effects on human heart","volume":"26","author":"Olivetti","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0220","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0225","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/eurheartj\/ehp047","article-title":"Cardiac troponin-I and risk of heart failure: a community-based cohort study","volume":"30","author":"Sundstr\u00f6m","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0230","first-page":"e99","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure","volume":"116","author":"Tang","year":"2007","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0235","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1515\/CCLM.2008.292","article-title":"Troponin revisited 2008: assay performance","volume":"46","author":"Tate","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0240","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.cardfail.2005.04.017","article-title":"Elecsys NT-ProBNP and BNP assays: are there analytically and clinically relevant differences?","volume":"11","author":"Yeo","year":"2005","journal-title":"J Card Fail"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0245","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0250","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9149(02)02464-5","article-title":"Impact of age and sex on plasma natriuretic peptide levels in healthy adults","volume":"90","author":"Wang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0255","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ahj.2004.01.013","article-title":"Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study","volume":"147","author":"Maisel","year":"2004","journal-title":"Am Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0260","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/j.ajkd.2005.06.017","article-title":"B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy","volume":"46","author":"Vickery","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.HYP.0000170140.36633.8f","article-title":"Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP","volume":"46","author":"Luchner","year":"2005","journal-title":"Hypertension"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0270","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.105.555573","article-title":"Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study","volume":"112","author":"Das","year":"2005","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0275","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.106.655142","article-title":"Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals","volume":"115","author":"Wang","year":"2007","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0280","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjmed.2003.08.037","article-title":"Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study","volume":"116","author":"Bibbins-Domingo","year":"2004","journal-title":"Am J Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0285","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jacc.2005.05.057","article-title":"Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study","volume":"46","author":"Knudsen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0290","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0735-1097(02)02608-6","article-title":"Cardiac troponins in renal insufficiency","volume":"40","author":"Freda","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0295","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.cca.2010.03.004","article-title":"Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure","volume":"411","author":"McGill","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0300","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1373\/clinchem.2009.132654","article-title":"Analytical validation of a high-sensitivity cardiac troponin T assay","volume":"56","author":"Giannitsis","year":"2010","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/01.CCM.0000055442.84685.4D","article-title":"Sex-based differences in serum cardiac troponin I. a specific marker for myocardial injury, after cardiac surgery","volume":"31","author":"Schwarzenberger","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0310","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/01.RES.85.9.856","article-title":"Myocyte death in the failing human heart is gender dependent","volume":"85","author":"Guerra","year":"1999","journal-title":"Circ Res"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0315","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ahj.2006.08.021","article-title":"Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results","volume":"152","author":"Wu","year":"2006","journal-title":"Am Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1373\/clinchem.2008.107391","article-title":"Short- and long-term biological variation in cardiac troponin I with a high-sensitive assay: Implications for clinical practice","volume":"55","author":"Wu","year":"2009","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0325","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0735-1097(03)00405-4","article-title":"Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study","volume":"41","author":"Maisel","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0330","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","article-title":"Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study","volume":"27","author":"Januzzi","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0335","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0340","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","article-title":"Contribution of30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project","volume":"121","author":"Blankenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0345","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1373\/clinchem.2007.101683","article-title":"Value of cardiac troponin I cut-off concentrations below the 99th percentile for clinical decision making","volume":"55","author":"Eggers","year":"2009","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0350","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ahj.2010.05.023","article-title":"The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes","volume":"160","author":"Lindahl","year":"2010","journal-title":"Am Heart J"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0355","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1373\/clinchem.2003.028316","article-title":"Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers","volume":"50","author":"Hammerer-Lercher","year":"2004","journal-title":"Clin Chem"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cccn.2003.10.027","article-title":"Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease","volume":"341","author":"Mueller","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0365","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1373\/clinchem.2006.075713","article-title":"Comparison of the diagnostic accuracy ofbrain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review","volume":"53","author":"Clerico","year":"2007","journal-title":"Clin Chem"},{"issue":"Suppl 2","key":"10.1097\/PAT.0b013e32834e786e_bib0370","first-page":"48","article-title":"The evaulation of the worth of early disease detection","volume":"16","author":"Wilson","year":"1968","journal-title":"J R Coll Gen Pract"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0375","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association (Erratum in: Circulation 2009; 119: e606.)","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0380","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7326\/0003-4819-138-11-200306030-00012","article-title":"The epidemiology of \u2018asymptomatic\u2019 left-ventricular dysfunction: implications for screening","volume":"138","author":"Wang","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0385","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cardfail.2009.01.005","article-title":"Preclinical systolic and diastolic dysfunction assessed by tissue doppler imaging is associated with elevated plasma pro-B-type natriuretic peptide concentrations","volume":"15","author":"Mogelvang","year":"2009","journal-title":"J Card Fail"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0390","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2009.943","article-title":"Novel and conventional biomarkers for prediction of incident cardiovascular events in the community","volume":"302","author":"Melander","year":"2009","journal-title":"JAMA"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0395","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.293.13.1609","article-title":"N-terminal pro-brain natriuretic peptide, C-rective protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults","volume":"293","author":"Kistorp","year":"2005","journal-title":"JAMA"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0400","first-page":"685","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. (Erratum in: N Engl J Med 1992; 327: 1768.)","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0405","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0410","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.553370","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0415","first-page":"13","article-title":"Natriuretic peptides in heart failure: should therapy be guided by BNP levels? (Erratum in: Nat Rev Cardiol 2010; 7: 178.)","volume":"7","author":"O\u2019Donoghue","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0420","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0735-1097(02)02625-6","article-title":"Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population","volume":"41","author":"Nielsen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0425","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2003.10.043","article-title":"Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction","volume":"43","author":"Heidenreich","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0430","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"10.1097\/PAT.0b013e32834e786e_bib0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"Bibbins-Domingo","year":"2007","journal-title":"JAMA"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251632582X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251632582X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:17:01Z","timestamp":1758471421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130251632582X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S003130251632582X"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e32834e786e","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/PAT.0b013e32834e786e","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}